Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 3, 2002, Pages 411-420

  Goldstein, Ellie J C ^a   Citron, Diane M ^a   Vreni Merriam, C ^a   Warren, Yumi A ^a   Tyrrell, Kerin L ^a   Fernandez, Helen T ^a  

^a Santa Monica UCLA Medical Center   (United States)

Author keywords

Anaerobes; Bite wounds; Cellulitis; Faropenem; Pasteurella

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CIPROFLOXACIN; DOXYCYCLINE; ERTAPENEM; ERYTHROMYCIN; FROPENEM; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ACINETOBACTER LWOFFII; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTEROIDES OVATUS; BITE; CONTROLLED STUDY; CORYNEBACTERIUM; CORYNEBACTERIUM AQUATICUM; CORYNEBACTERIUM MINUTISSIMUM; DRUG STRUCTURE; EIKENELLA CORRODENS; IN VITRO STUDY; LACTOBACILLUS DELBRUECKII; NONHUMAN; PASTEURELLA; PEPTOSTREPTOCOCCUS; PEPTOSTREPTOCOCCUS TETRADIUS; SKIN INFECTION; SOFT TISSUE INFECTION; VEILLONELLA;

EID: 0036733525     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf139     Document Type: Article

References (10)

1. The bacteriology and management of dog and cat bite wound infections presenting to Emergency Departments
2. Pharmacodynamic properties of faropenem demonstrated by studies of time-kill kinetics and postantibiotic effect
3. Activities of faropenem, an oral β-lactam, against recent U. S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
4. The in-vitro activity of faropenem, a novel oral penem
5. Faropenem enhances superoxide anion production by human neutrophils, in vitro
6. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity
7. In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections
8. Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections
9. Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens
10. Comparative in-vitro activity of faropenem against staphylococci